Advancing Severe Migraine Care

Where

Virtual

When

{{getUserDateTimezone("1730743200").singleDate}}
{{getUserDateTimezone("1730743200").time}} - {{getUserDateTimezone("1730745000").time}} {{getClientTimezoneName()}}

About

Migraine can have a debilitating effect on a person’s quality of life, with diagnosis and care often complicated by pervasive misconceptions and a lack of early preventive treatment.

This virtual event explores the impact of severe migraine, traces the evolution of clinical trials to capture meaningful outcomes, and underscores the critical need for conversation between health care providers and patients navigating treatment options.

Moderator

Jesse McQuarters, Branded Content Editor at STAT

Speakers

Damian Fiore, Vice President, US Medical Affairs Neurology, Lundbeck

Damian Fiore, PharmD, joined Lundbeck in August 2022 as the Vice President of US Medical Affairs Neurology. In his role, Damian leads the US neurology medical affairs team and supports the broader Lundbeck migraine pipeline. Damian has more than 20 years of experience in drug development in Neurology, including multiple sclerosis and migraine.

Shoshana Lipson, Executive Director, Migraine Meanderings; President, Migraine Patient Leader Hope in Pain, Inc

Shoshana Lipson is a patient advocate, speaker, and writer. She has a passion to encourage, support, educate and inspire people living with migraine & chronic pain disorders, to find purpose and value in the midst of illness, and not give up hope. Shoshana leads an online community of over 30,000 members through Migraine Meanderings and Hope for Migraine, and in 2021 launched a new initiative called, Empowering Patient Voices. Shoshana collaborates with various advocacy organizations and pharmaceutical companies, is a contributing writer for Migraine.com, and speaks regularly on the topic of patient centricity.

Amaal Starling, M.D., Associate Professor, Department of Neurology, Mayo Clinic College of Medicine and Science

Dr. Amaal Starling is an Associate Professor of Neurology in the Mayo Clinic College of Medicine and Science. She joined Mayo in 2012 and is currently a board-certified Consultant within the Department of Neurology. She is presently the Program Director for the Headache Medicine Fellowship and the Program Director for the Transitional Year Residency Program in the Mayo Clinic College of Medicine and Science – Arizona Campus. She is a Fellow of the American Academy of Neurology (AAN) and the American Headache Society (AHS). Dr. Starling currently serves on the Board of Directors for the American Headache Society and is the Chair of the Advocacy Committee.